Amlodipine/valsartan fixed-dose combination treatment in the management of hypertension: A double-blind, randomized trial

To compare the fixed-dose combination (FDC) of amlodipine/valsartan 5/80 mg with valsartan 160 mg monotherapy for efficacy and safety in hypertensive patients. METHODS: We designed this double-blind, randomized, and noninferiority trial in which patients with elevated systolic blood pressure (SBP) a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Chin Med Assoc
Hlavní autoři: Wang, Kang-Ling, Yu, Wen-Chung, Lu, Tse-Min, Chen, Lung-Ching, Leu, Hsin-Bang, Chiang, Chern-En
Médium: Artigo
Jazyk:Inglês
Vydáno: Lippincott Williams & Wilkins 2020
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7526577/
https://ncbi.nlm.nih.gov/pubmed/33009241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JCMA.0000000000000386
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky